By Wayne J M Karim Could a nation defined by inflammation find relief in psychedelics? It’s a verifiable truth that the United States of America may be considered a global leader, especially when it comes to the prevalence of mental and physical health disorders. In fact, of the nearly 330 million people in the population, …

The post Inflammation Nation: How Psychedelics Could Combat Widespread Chronic Pain appeared first on Psychedelics Today.

Previous articleatai Life Sciences Announces First Subject Dosed in Phase 1 Trial of Buccal and IV VLS-01, a Synthetic Form of DMT
Next articlePharmaTher Holdings Announces Grant of U.S. Patent Covering Ketamine for Parkinson’s Disease